The la.rt decade suw ' u ihmiatic. change 
Introduction
During the last decade, enonnous progress was achieved in the area of interventional procedures performed with a catheter. These procedures include maneuvers to create intracardiac shunts by balloon atrial septostomy and blade septeclomy as well as procedures that close intra-and extracardiac communications, and open obstructions in valves and vesscls. The capability of performing these procedures with a catheter enhances and improves the treatment of patients with congcnital heart disease. During the same h i e , two-dimensional and Doppler ultrasound reached a level in which it is considered the preferable noninvasive diagnostic technique for congenital heart disease in children. Improvement of resolution, penetration, and image quality brought ultrasound to the leading edge of imaging modalities.
Three approaches are used in cardiac ultrasound: transthoracic: transesophageal; and intravascular. Thesc three mcthods allow the sonographer to visual-ize the heart through different channels giving the catheterizer the option to choose the preferable one. During the last decade, interventional catheterization and ultrasound "married each other" in order to achieve the highest level of accuracy and precision in thesc procedures. Ultrasound is being used to diagnose, guide, and evaluate immediate and late results of intervcntional procedures. This article describes the use of echocardiography in different interventional procedures. the cxistence of an atrial septum aneurysm or strings across the defect and a fenestration appearance. Thcse factors can significantly affect the success of the interventional procedure. Visualization of the catheter course through the inferior vena cava or the superior vena cava into the right atrium and then across atrial septum to the left atrium is crucial. Once the catheter is identified in the right atrium, the echocardiographer has to be sure that the catheter crosses the atrial septum into the left atrium and is not covered by septum primum. Using fluoroscopy alone can mislead and suggest that the catheter is already in the left atrium, but the existence of membrane covering the catheter is not visualized by this technique. Once the catheter is introduced into the left atrium, before inflating the balloon andlor opening the blade, ultrasound can help in localization of the tip of the catheter. The balloon must not be inflated if the tip of the catheter is situated either in one of the pulmonary veins or the mitral valve apparatus. Once the balloon is inflated or the blade is open, guidance of the procedure itself is possible. After crossing the atrial septum from left to right, the balloon should be deflated immediately and the blade should be closed and withdrawn ( Figs. 1 and 2) .
The immediate result of this procedure is evaluated by visualization of the atrial septum and ASD that was created. Color Doppler demonstrates the shunt and specifies the direction of the flow across the atrial septum. According to several authors, the ASD should exceed 45% of the total atrial septum diameter.2 Doppler evaluation of the shunt flow velocity can be used to demonstrate that the septal defect is nonrestrictive. Another important feature that indicates a successful procedure is free flail of the vaIve of the foramen ovale. Balloon septostomy with ultrasound guidance is being done at the bedside in several institutions. Our recommendation is that this procedure under ultrasound imaging should still be done in the catheterization lab, and immediate results and guidance should be provided by both invasive and noninvasive techniques.
Balloon Dilation of Stenotic Valves and Coarctation on the Aorta
Echocardiography in these conditions can provide the catheterizer with accurate anatomical and pathological details of the specific lesions. Accurate measurement of the valve annulus diameter in case of aortic or pulmonary valve stenosis is crucial for the selection of balloon size. The existence of a unicuspid or dysplastic valve in the aortic or pulmonary position may direct the catheterizer toward different approaches of treatment. Echocardiography should describe any possibility of subvalvc or supravalve obstruction as an additional lesion. Tn the catheterization laboratory. ultrasound can identify if the catheters arc centered across those valves before inflating the balloon. Immediate evaluation of residual obstruction and the amount of insufficiency caused by balloon dilation should be performed following the dilation procedure. The amount of valve insufficiency is evaluated by color flow and other Doppler techniques. In the case of cusp perforation or avulsion, ultrasound identifies the event immediately and accurate measurements should be taken.
In coarctation of the aorta, echocardiography should delineate the anatomy and differentiate between a discrete posterior shelf or long segment stenosis. When using transesophageal echocardiography imaging will measure the area of the coarctation by using the transverse and the longitudinal planes. Lately. the use of intcrvascular imaging during this procedure has improved the delineation of the diameter of the narrowest segment and the wall morphology. In several reports, a tear of the intima was seen immediatcly aftcr balloon dilation of coarctation (Fig. 3) . l n some authors' opinion, an absence of a tear in the intima indicates a relative failure of this procedure. Follow-up studies showed that the majority of these tears heal without aortic aneurysm formation. Doppler techniques may be used in these cases in order to evaluate the pulsatility and distensibility of the descending aorta before and after this procedure. We have learned that both indices increased after a successful procedure and can be used as predictors of 
Closure of Shunt Lesions: Atrial Septal Defect, Ventricular Septal Defect, and Patent Ductus Arteriosus
The evolutioii of transesophageal echocardiography opened a new window for cardiac imaging. The proximity of the esophagus to the left atrium facilitates the imaging of the posterior structures of the heart and providcs an accurate visualization of all parts of the atrial septum.
Atrial Septal Defect Closure. Two devices are currently undergoing clinical investigations to close the secundurn ASD: (1) the double umbrella device which attaches to the septum by two opposing umbrellas held against opposite sides of the septum by a spring mecha n i s~n ;~ and (2) the button device.' The metal components of these devices can be seen by fluoroscopy, but neither the ASD nor the atrial septum itself can be seen on fluoroscopy. ately after implantation.
Atrial septal defect visualization. One of the most critical aspects of ASD closure is the accurate determination of which defect will or will not be suitable for device closure. The current ASD device must be two times larger than the stretched size of the ASD.6 Transesophageal echocardiography has proven to be extremely useful, if not essential, in the imaging for the atrial septum for ASD measurement. ASDs with an unusually high or low position may require further evaluation. The atrial septum must have proper length and an adequate upper and lower rim to accommodate the total diameter of the device. The atrial septum is anatomically a concave-convex structure. Balloon stretching techniquejtx atrial septal defect sizing. ASD size is measured by the balloon sizing technique in all patients during cardiac catheterization. The balloon is well seen using fluoroscopy, but fluoroscopy does not allow the catheterizer to evaluate the location of the balloon within the atrial septum, or to visualize the upper and lower septal rims. Even though the balloon is "caught" by the atrial septum as it is pulled slowly from the left to the right atrium, transatrial shunts around the balloon can still exist and could mislead the catheterizer in the selection of the desirable device (Fig. 6 ). Pulsed and color flow Doppler can save the patient from unnecessary radiation and serve as a very sensitive modality for the detection of leaks across the sizing balloon. When a residual leak across the balloon is documented, the catheterizer is requested to inflate the balloon for a larger diameter until no residual leaks are visualized. 8 Localization of the device. Transesophageal echocardiography assists in the localization of the tip of the sheath and/or catheter before the release of the device, and thereby prevents opening of the legs in the pulmonary veins or left atrial appendage or in proximity to the mitral valve. Because of the existence of the septum primum, the catheter may distort the septum toward the left atrium. The possibility of deploying the device near the septum primum on the right side of the septum creates a potential hazard ECHOCARDIOGRAPHY IN INTERVENTIONAL PROCEDURES (Fig. 7) . Releasing the device close to the mitral and/or tricuspid valve may result in atrioventricular valve regurgitation. This should be assessed immediately by direct visualization and by color flow Doppler and thc device position adjusted if necessary. It is important to visualize all eight legs of the device in the case of the Clamshell device (USCI, C.R. Bard, Billerica, MA, USA), and all six legs of the button device. This task is sometimes difficult because the legs may lie in different planes (Figs. 8 and 9) . ' The fenestrated utrial septal defect. Transthoracic echocardiographic imaging of an ASD is sometimes limited by poor acoustic windows. Fenestrated ASDs introduce a major problem for transcatheter occlusion procedures. If a fenestrated ASD exists, the size of the actual defect could be underestimated (Fig. 10) . The balloon stretching technique will not serve as an accurate measurement for the ASD if the balloon is trapped between the fenestration strands. In this case, the goal of the catheterizer will be to choose a device that will cover the whole ASD, including the fenestrated area. Vol. 8, No. 5. 1995 
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We have found that transesophageal echocardiography is essential for identification and management of fenestrated ASDS.'' Residual leaks across a device. Color flow Doppler is very sensitive in detection of residual leaks across ASD devices. Small residual leaks are often seen immediately after implantation, but in many cases, complete closure is obtained within 15 minutes. It is important to localize the residual leaks in order to guide further follow-up evaluation with both transthoracic and transesophageal echocardiography. If a large leak is present, a second device implantation is an option in the future. Ventricular Septa1 Defect Closure. Echocardiography has a major role in the definition of the VSD and in the monitoring and guidance of its closure by a device. l 1 Each patient should be carefully evaluated by transthoracic echocardiography before entering the catheterization laboratory. In cases of apical muscular VSDs, the echocardiography visualization could be accurate using the transthoracic approach than the transesophageal approach (Fig. 1 1) . Transesopha- 
Pericardiocen tesis
Pericardiocentesis is done by introducing a needle or catheter into the pericardial sac and evacuating the pel-icardial fluid. Illtrasound is the best imaging modality to diagnose the existence, spread, location. and the amount of fluid. Using a transthoracic and/or transesophageal approach, the exact localization (i.e.. anterior, posterior, circumferential, or localized) of the effusion can be made. Before the procedure is performed. the exact location of the effusion i s critical for guiding the pericxdiocentesis procedure. Tf needle position is unclear, a cautious maneuver can be taken by injecting effusion fluid back into the space in order to visualize bubbles in the pericardial sac. After evacuation of the fluid, repeat assessment of effusion size and ventricular function as well as possible atrial compromise should be performed. Doppler technique can identify very early alteration in diastolic ventricular function. This finding should disappear after successful evacuation of this fluid. In cases of emergency, this proccdure can be done at the bedside, but our recommendation is to perform pel-icardiocentesis in the catheterization lab under direct visualization by echocardiography ilnd iluoroscopy.
Conclusion
In general, with the improvement of available ultrasound modalities, (i.e.. transesophageal transducers, miniaturization of devices) we envision more coopcration between cardiac catheterization and echocardiography. New echocardiographic modalities will enable us to perform on-line three-dimensional reconstruction in the near future. This technology together with the development of improved transluminal imaging will define echocardiography as a major participant in inany pediatric intcrvcntional procedures in the future.
